title: [Study on pharmacokinetics-pharmacodynamics correlation of yin teng gu bi kang prescription].
abstract: OBJECTIVE
  To study pharmacokinetics-pharmacodynamics (PK-PD) correlation of Yin Teng Gu Bi Kang (YTGBK) prescription through determination of Tanshinone II(A) concentration and the level of Malondialdehyde (MDA) in plasma in normal and blood stasis rats treated with YTGBK prescription.
  
  
  METHODS
  The concentration of Tanshinone II(A) in the plasma was measured by HPLC-UV and loratadine was used as internal standard; Thiobarbituric acid reactive substance assay (TBARS) was adopted to determine the concentration of MDA in the plasma Area under the concentration-time curve (AUC) and area under the effect-time curve (AUE) were calculated using linear trapezoid rule. The correlation and regression analysis was performed by plotting AUE (Y) versus lgAUC (X) using linear regression.
  
  
  RESULTS
  YTGBK prescription could significantly decrease MDA level in the plasma in above two different physiological rats at the analyzed time point (P < 0.05). Scatter plots of AUE-lgAUC showed an upward trend. The results of the correlation and regression analysis were as follows: Y = 53.367 X -30.780, r = 0. 822, P = 0.007 for normal rats and Y = 61.091 X -39.863, r = 0.777, P = 0.003 for model rats, respectively.
  
  
  CONCLUSIONS
  There is a positive correlation between Tanshinone II(A) level in plasma and the antioxidant activity of YTGBK prescription in decreasing MDA level, which indicates that Tanshinone II(A) is the antioxidant effective substance of YTGBK prescription.
authors.forename: Yuan-Qing
authors.initials: YQ
authors.lastname: Wang
authors.forename: Jian-Ye
authors.initials: JY
authors.lastname: Yan
authors.forename: Shun-Xiang
authors.initials: SX
authors.lastname: Li
authors.forename: Kun
authors.initials: K
authors.lastname: Luo
authors.forename: Mai-Jiao
authors.initials: MJ
authors.lastname: Peng
authors.forename: Yu
authors.initials: Y
authors.lastname: Xie
authors.forename: Fei
authors.initials: F
authors.lastname: Xu
mesh_terms: D045784:Abietanes / Q000097:blood*; D000284:Administration, Oral; D000818:Animals; D000975:Antioxidants / Q000493:pharmacokinetics* / Q000494:pharmacology; D019540:Area Under Curve; D001777:Blood Coagulation / Q000187:drug effects*; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D004195:Disease Models, Animal; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal / Q000493:pharmacokinetics* / Q000494:pharmacology; D008297:Male; D008315:Malondialdehyde / Q000097:blood*; D010946:Plants, Medicinal / Q000737:chemistry; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D045784:Abietanes; D000975:Antioxidants; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; C021751:tanshinone; D008315:Malondialdehyde